ITGI Medical Surges in Tel Aviv After Getting European Permit

ITGI Medical Ltd. (ITGI) rose to the highest level in almost two months as the bio-medical company said it completed the development of a new series of stents for which it got the European CE Mark quality permit.

The shares surged 35 percent to 0.096 shekel, the highest intraday level since Feb. 27, at 12:54 p.m. in Tel Aviv, giving the company a market value of 11 million shekels ($3 million).

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.